£1.9M
The seed round was co-led by Oxford Capital and YZR to fund expansion into international markets.
"Increasing access to the right diagnostic imaging and testing is vital to saving lives. It offers preventive healthcare that, if delayed, can cause significant problems to the patient and put even greater pressure on the healthcare system. In my role as an osteopath I've seen how the deterioration of patient wellbeing can be impacted by the cost and access of such tests. With this new investment we can continue to grow our network to get the tests that help to direct patients to the optimal therapy for the best outcome."
Oxford Capital + 3 others
